WYETH for WYETH

Trade (domestic/foreign) TRD

Monitor U.S. trade policies relating to intellectual property protection under the WTO TRIPS agreement Importation of FDA-approved pharmaceuticals

Contacted: Office of the Vice President of the United States; White House Office; Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Natl Security Council (NSC); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Justice, Dept of (DOJ); Treasury, Dept of; SENATE; Natl Security Agency (NSA); Food & Drug Administration (FDA); Executive Office of the President (EOP)

Taxation/Internal Revenue Code TAX

Taxation of International Operations of U.S. corporations generally R&D tax credit Taxation of Deferred Compensation Plans Foreign tax credit legislation; Homeland investment legislation

Contacted: Food & Drug Administration (FDA); White House Office; U.S. Trade Representative (USTR); Treasury, Dept of; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Natl Security Agency (NSA); SENATE; Executive Office of the President (EOP); State, Dept of (DOS); Office of the Vice President of the United States; Natl Security Council (NSC); Centers For Medicare and Medicaid Services (CMS); Justice, Dept of (DOJ)

Copyright/Patent/Trademark CPT

Monitor U.S. trade policies relating to intellectual property protection under the WTO/TRIPS agreement H.R. 1908 Patent Reform Act of 2007 S. 1145 Patent Reform Act of 2007

Contacted: Treasury, Dept of; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Natl Security Council (NSC); Executive Office of the President (EOP); Office of the Vice President of the United States; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; Justice, Dept of (DOJ); White House Office; U.S. Trade Representative (USTR); Natl Security Agency (NSA); State, Dept of (DOS)

Bills named: S. 1145 (110th), H.R. 1908 (110th)

Health Issues HCR

Vaccine Injury Compensation Program Follow developments within the Bush Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies HR 3610 HR 5629 Issues relating to support of Office of Women's Health and Public Education Initiatives Childhood immunizations Dietary supplement issues FDA reform issues Implementation issues concerning P.L. 108-173 - The Medicare Prescription Drug, Improvement and Modernization Act of 2003 Drug compounding Drug advertising Alzheimer's care Comparative effectiveness S. 1695 Biologics Price Competition and Innovation Act of 2007 Issues related to hormone therapy H.R. 3043 - Labor/HHS Appropriations Act of 2008 S. 1276 - Methamphetamine Production Prevention Act of 2007 H.R. 1812 - Menopausal Hormone Replacement Therapies and Alternative Treatments and Fairness Act Pediatric Studies and Trials Follow-on biologics Drug importation and counterfeiting Drug Safety/Clinical Trials H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 S. 623/HR 1038 - Access to Life Saving Medicine Act, Follow-on Biologics S. 1505 - Affordable Biologics for Consumers Act H.R. 3610 - Food and Drug Import Safety Act of 2007 S.2029 - Vaccine Safety and Payment Health care issues Drug approvals Reimbursement rates

Contacted: Treasury, Dept of; SENATE; Natl Security Agency (NSA); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Office of the Vice President of the United States; Natl Security Council (NSC); Centers For Medicare and Medicaid Services (CMS); Justice, Dept of (DOJ); U.S. Trade Representative (USTR); Executive Office of the President (EOP); State, Dept of (DOS); Health & Human Services, Dept of (HHS); White House Office

Bills named: H.R. 5629 (110th), H.R. 1812 (110th), H.R. 3610 (110th), S. 1276 (110th), S. 623 (110th), H.R. 3043 (110th), S. 1695 (110th), S. 1505 (110th), S. 2029 (110th), H.R. 1038 (110th), H.R. 1956 (110th)

Medicare/Medicaid MMM

Methamphetamines Vaccines Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Issues relating to Medicaid reimbursement for drugs/biologics in Title VI of S.1932-the Deficit Reduction Act of 2005 Pediatric Exclusivity H.R. 4 - Medicare Prescription Drug Price Negotiation Act H.R. 3162 - Children's Health and Medicare Protection Act of 2007 S.1893/H.R. 976 - Children's Health Insurance Progam Reauthorization Act of 2007 S. 2499 - Medicare, Medicaid and SCHIP Extension Act of 2007 Chronic care out of pocket costs S. 2029 - Physician Payments Sunshine Act of 2007 HR 5605 - Physician Payments Sunshine Act of 2007 HR 2185 - Enhanced Healthcare Value for All Act Medicare Physician Reimbursement package Medicare and Medicaid Drug Reimbursement Medicaid Rebate Medicaid Part D Non-Interference

Contacted: Office of the Vice President of the United States; Food & Drug Administration (FDA); SENATE; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Natl Security Agency (NSA); HOUSE OF REPRESENTATIVES; Justice, Dept of (DOJ); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Natl Security Council (NSC); Treasury, Dept of; State, Dept of (DOS); White House Office

Bills named: S. 1893 (110th), H.R. 2185 (110th), H.R. 5605 (110th), H.R. 3162 (110th), S. 1932 (110th), S. 2029 (110th), S. 2499 (110th), H.R. 4 (110th), H.R. 976 (110th)

Budget/Appropriations BUD

Pharmaceutical drug importation; Labor HHS Appropriations; Medicare and Medicaid Drug Reimbursement S.Con.Res 70/H.Con.Res 312 - FY 2009 Budget Resolution

Contacted: State, Dept of (DOS); White House Office; Justice, Dept of (DOJ); Office of the Vice President of the United States; SENATE; Health & Human Services, Dept of (HHS); Natl Security Agency (NSA); Executive Office of the President (EOP); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Natl Security Council (NSC); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Treasury, Dept of

Bills named: H.Con.Res. 312 (110th), S.Con.Res. 70 (110th)

Consumer Issues/Safety/Products CSP

FDA reform proposals; Pseudoephedrine S. 1276 Methamphetamine Production Preventation Act of 2007 H.R. 970 DXM Distribution Act S. 1378 DXM Distribution Act DXM Abuse Monograph System Reform Proposal S. 2274 DXM Abuse Reduction Act H.R. 4083 Non-Prescription Drug modernization Act of 2007

Contacted: Executive Office of the President (EOP); Office of the Vice President of the United States; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); Natl Security Council (NSC); U.S. Trade Representative (USTR); Justice, Dept of (DOJ); SENATE; Natl Security Agency (NSA); HOUSE OF REPRESENTATIVES; White House Office; Treasury, Dept of

Bills named: H.R. 970 (110th), S. 1378 (110th), S. 2274 (110th), S. 1276 (110th), H.R. 4083 (110th)

Pharmacy PHA

H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 S. 623/HR 1038 - Access to Life-Saving Medicine Act, Follow-on Biologics S.1695 - Biologics Price Competition and Innovation Act of 2007 S1505- Affordable Biologics for Consumers Act H.R. 5629 - "Pathway for Biosimilars Act" H.R. 3610 - Food and Drug Import Safety Act of 2007 Biosimilars Drug Safety Prescription Drug Importation Import Safety

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE; U.S. Trade Representative (USTR); Natl Security Council (NSC); White House Office; Office of the Vice President of the United States; Justice, Dept of (DOJ); Treasury, Dept of; Executive Office of the President (EOP); State, Dept of (DOS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Natl Security Agency (NSA)

Bills named: S. 1695 (110th), H.R. 5629 (110th), H.R. 1956 (110th), H.R. 3610 (110th), H.R. 1038 (110th), S. 623 (110th)